Sign in
4/A

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001567619-22-007727

SVP, Operations acquired 25,328 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Turney Patricia A. · SVP, Operations

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-23 Exercise or conversion : show line 1 in the form +25,328 $6.52 $165,139 56,441 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-03-23 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −25,328 $6.52 2029-11-20 25,328 134,615 D
Loading xslF345X03/doc1.xml…